Physician profile
Karen Barb
NPI 1659363521
$803.83
in general payments reported to CMS, 2019-2025
13 companies · $235 in 2025
The $235 reported for 2025 was more than what 79% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $159 · 2022: $143 · 2023: $141 · 2024: $126 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $501.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $156.73 | 2021-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $126.31 | 2023-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Takeda Pharmaceuticals U.S.A., INC. | $94.36 | 2021-2022 | |
| Cranial Technologies, INC | $89.44 | 2021-2025 | Doc Band |
| Pfizer INC. | $84.65 | 2024-2025 | |
| Corium, LLC | $49.86 | 2023-2024 | Azstarys |
| Sanofi Pasteur INC. | $43.81 | 2021-2023 | |
| Collegium Pharmaceutical, INC. | $39.85 | 2025 | Jornay Pm |
| Kowa Pharmaceuticals America, INC. | $28.73 | 2024-2025 | Zoryve |
| Kaleo, INC. | $26.09 | 2022 | |
| Sobi, INC | $24.81 | 2021 | |
| Genentech USA, INC. | $22.33 | 2021 | |
| Vertical Pharmaceuticals, LLC | $16.86 | 2024 | Relexxii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Barb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.